Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Ovarian Cycle01:27

Ovarian Cycle

1.5K
The menstrual cycle includes a critical component known as the ovarian cycle, which undergoes two main phases each month—the follicular phase and the luteal phase. The follicular phase is variable and averaging around 14 days. Ovulation, triggered by a surge in luteinizing hormone (LH), marks the transition between the two phases. The second phase, the luteal phase, is relatively consistent, lasting approximately 14 days, and is marked by the activity of the corpus luteum. While a cycle...
1.5K
Hormonal Control of the Ovarian Cycle01:30

Hormonal Control of the Ovarian Cycle

607
The ovarian cycle is meticulously regulated by the hypothalamic-pituitary-gonadal axis. This cycle orchestrates the release of a mature oocyte, essential for reproduction.
Before puberty, the hypothalamus releases GnRH in a low frequency, low amplitude pulsatile manner. This along with the immature hypothalamic-pituitary-gonadal axis activity, results in low estrogen levels and the absence of a fully functional ovarian cycle.  At puberty, GnRH secretion increases in both frequency and...
607
Oogenesis02:07

Oogenesis

63.9K
In human women, oogenesis produces one mature egg cell or ovum for every precursor cell that enters meiosis. This process differs in two unique ways from the equivalent procedure of spermatogenesis in males. First, meiotic divisions during oogenesis are asymmetric, meaning that a large oocyte (containing most of the cytoplasm) and minor polar body are produced as a result of meiosis I, and again following meiosis II. Since only oocytes will go on to form embryos if fertilized, this unequal...
63.9K
Infertility in Females01:28

Infertility in Females

360
Female infertility is defined as the inability to conceive after a year of regular, unprotected intercourse and affects about 10–15% of couples worldwide. The primary cause of female infertility is ovulatory disorders, which hinder the release of eggs. These disorders can be classified as hypothalamic amenorrhea, polycystic ovarian syndrome (PCOS), premature ovarian failure, and hyperprolactinemic anovulation disorders.
Endometriosis, a condition characterized by abnormal growth of...
360
Disorders of the Female Reproductive System01:24

Disorders of the Female Reproductive System

431
The female reproductive system can be affected by several disorders, including Premenstrual Syndrome (PMS), Premenstrual Dysphoric Disorder (PMDD), endometriosis, and various forms of cancer. PMS and PMDD are cyclical conditions that cause physical and emotional distress, with symptoms that include edema, mood swings, and food cravings. PMDD is a more severe form of PMS characterized by increased symptom severity that peaks during the luteal phase and tends to improve or resolve shortly after...
431
Folliculogenesis01:20

Folliculogenesis

922
Folliculogenesis is the development of ovarian follicles, the specialized structures within the ovarian cortex where oogenesis, or egg development, occurs. This process is essential for female reproductive health and begins during fetal development when primordial follicles are formed. Each primordial follicle comprises a primary oocyte in the center, surrounded by a single layer of squamous pre-granulosa cells. These follicles remain dormant in late prophase I of meiosis until triggered by...
922

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Scaling Up Community-based Noncommunicable Disease Research into Practice in Pokhara Metropolitan City of Nepal (SCALE-NCD) trial: study protocol for a cluster-randomized controlled trial.

Research square·2026
Same author

Acute psychological stress transiently increases arterial stiffness in young adults.

Journal of human hypertension·2026
Same author

Intervention mapping to develop a patient-advocate enhanced program to reduce sedentary behavior in endometrial cancer survivors.

Journal of cancer survivorship : research and practice·2026
Same author

Health behaviors among young adult cancer survivors and the importance of task self-efficacy.

Journal of cancer survivorship : research and practice·2026
Same author

Integrating Athlete Perspectives and Head Kinematics in Youth American Football.

Journal of applied biomechanics·2026
Same author

Infant With an Asymmetrical Smile.

American family physician·2026
Same journal

For Post-stent Patients With Atherosclerotic Coronary Vascular Disease Who Are Taking an Anticoagulant, Adding Aspirin Worsens Outcomes.

American family physician·2026
Same journal

Nausea and Vomiting During Pregnancy.

American family physician·2026
Same journal

Metabolic Dysfunction-Associated Steatotic Liver Disease: Diagnosis and Management.

American family physician·2026
Same journal

Aerobic Exercise Is the Better Exercise Modality for Knee Osteoarthritis.

American family physician·2026
Same journal

Overscreening Leads to Overdiagnosis of MASLD.

American family physician·2026
Same journal

Type 2 Diabetes: Outpatient Insulin Management.

American family physician·2026
See all related articles

Related Experiment Video

Updated: Aug 6, 2025

Evaluation of Hepatic Glucose Production in a Polycystic Ovary Syndrome Mouse Model
09:44

Evaluation of Hepatic Glucose Production in a Polycystic Ovary Syndrome Mouse Model

Published on: March 5, 2022

3.0K

Polycystic Ovary Syndrome: Common Questions and Answers.

Tracy Williams1, Justin B Moore1, Jared Regehr1

  • 1University of Kansas School of Medicine, Wichita, Kansas.

American Family Physician
|March 15, 2023
PubMed
Summary
This summary is machine-generated.

Polycystic ovary syndrome (PCOS) is a common hormonal disorder in women. Management focuses on lifestyle changes, with treatments tailored to pregnancy desires and symptoms like irregular periods or acne.

More Related Videos

Author Spotlight: Investigating the Mechanisms and Inducing Models of Polycystic Ovary Syndrome
04:49

Author Spotlight: Investigating the Mechanisms and Inducing Models of Polycystic Ovary Syndrome

Published on: July 5, 2024

1.1K
A Hyperandrogenic Mouse Model to Study Polycystic Ovary Syndrome
08:20

A Hyperandrogenic Mouse Model to Study Polycystic Ovary Syndrome

Published on: October 2, 2018

11.3K

Related Experiment Videos

Last Updated: Aug 6, 2025

Evaluation of Hepatic Glucose Production in a Polycystic Ovary Syndrome Mouse Model
09:44

Evaluation of Hepatic Glucose Production in a Polycystic Ovary Syndrome Mouse Model

Published on: March 5, 2022

3.0K
Author Spotlight: Investigating the Mechanisms and Inducing Models of Polycystic Ovary Syndrome
04:49

Author Spotlight: Investigating the Mechanisms and Inducing Models of Polycystic Ovary Syndrome

Published on: July 5, 2024

1.1K
A Hyperandrogenic Mouse Model to Study Polycystic Ovary Syndrome
08:20

A Hyperandrogenic Mouse Model to Study Polycystic Ovary Syndrome

Published on: October 2, 2018

11.3K

Area of Science:

  • Reproductive Endocrinology
  • Metabolic Disorders
  • Women's Health

Background:

  • Polycystic ovary syndrome (PCOS) is the most prevalent endocrinopathy in women of reproductive age.
  • Its pathophysiology involves genetic and environmental factors, leading to insulin resistance.
  • PCOS is diagnosed clinically using the Rotterdam criteria (oligoanovulation, hyperandrogenism, polycystic ovaries).

Purpose of the Study:

  • To outline the diagnostic criteria for PCOS.
  • To describe the common clinical manifestations and associated health risks.
  • To detail the therapeutic strategies for PCOS management.

Main Methods:

  • Diagnosis relies on clinical presentation and Rotterdam criteria.
  • Treatment involves lifestyle modifications as the cornerstone.
  • Pharmacological interventions are selected based on patient goals (pregnancy or symptom management).

Main Results:

  • PCOS is linked to hirsutism, acne, menstrual dysfunction, dysglycemia, dyslipidemia, obesity, and increased risks of cardiovascular disease and endometrial cancer.
  • First-line therapy for non-pregnant patients includes oral contraceptives and antiandrogens.
  • For pregnant patients, letrozole is the primary ovulation induction agent; metformin is used for metabolic complications.

Conclusions:

  • Lifestyle modification is fundamental for PCOS management.
  • Treatment is individualized based on fertility desires and clinical presentation.
  • Screening for associated conditions like depression and sleep apnea is recommended.